Abstract
The use of digoxin in patients having atrial fibrillation (AF) with or without heart failure (HF) is not without controversy. The aim of this study was to examine the impact of digoxin therapy on mortality stratified by HF. Gulf Survey of Atrial Fibrillation Events was a prospective, multinational, observational registry of consecutive patients with AF recruited from the emergency department of 23 hospitals in 6 countries in the Middle East. Patients were recruited between October 2009 and June 2010 and followed up for 1 year after enrollment. Analyses were performed using univariate and multivariate statistical techniques. The study included a total of 1962 patients with AF, with an overall mean age of 56 ± 16 years, and 52% (n = 1026) were males. At hospital discharge, digoxin was prescribed in 36% (n = 709) of the patients, whereas HF was present in 27% (n = 528) of the cohort. A total of 225 (12.1%) patients died during the 12-month follow-up period after discharge (5.3% [n = 104] were lost to follow-up). Patients with HF were consistently associated with higher mortality at 1 month (5.1% vs 2.1%; P < .001), 6 months (17.2% vs 5.0%; P < 0.001), and 12 months (24.3% vs 7.6%; P < .001) when compared to those without HF. When ...Continue Reading
References
Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Jul 1, 2004·Circulation·Robert L McNamaraUNKNOWN American Heart Association
Apr 21, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Julio A ChirinosYeon S Ahn
May 8, 2007·Heart·K GjesdalS B Olsson
Aug 9, 2007·European Journal of Clinical Pharmacology·Pär HallbergUNKNOWN RIKS-HIA group
Aug 28, 2009·Heart·L FribergM Rosenqvist
Jun 26, 2010·Journal of the American Society of Nephrology : JASN·Kevin E ChanRaymond M Hakim
Aug 31, 2010·European Heart Journal·A John CammFrans H Rutten
Jul 21, 2011·Circulation. Cardiovascular Quality and Outcomes·Mohammad ZubaidUNKNOWN Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Investigators
Jul 26, 2012·European Journal of Heart Failure·John J V McMurrayUNKNOWN ESC Committee for Practice Guidelines
Nov 29, 2012·European Heart Journal·Matthew G WhitbeckClaude S Elayi
Apr 18, 2013·European Heart Journal·Mihai GheorghiadeAli Ahmed
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Sep 12, 2013·Circulation. Cardiovascular Quality and Outcomes·James V FreemanAlan S Go
Dec 5, 2013·Circulation. Heart Failure·Isaac SeeDaniel S Budnitz
Apr 1, 2014·Circulation·Craig T JanuaryClyde W Yancy
Jun 7, 2014·Angiology·Mohammad ZubaidUNKNOWN Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Investigators
Jun 14, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Bart A MulderUNKNOWN RACE II Investigators
Jun 22, 2014·The American Journal of Cardiology·Mitesh ShahLouise Pilote
Aug 16, 2014·Journal of the American College of Cardiology·Mintu P TurakhiaPaul A Heidenreich
Sep 30, 2014·The Canadian Journal of Cardiology·Tze-Fan ChaoShih-Ann Chen
Dec 3, 2014·International Journal of Cardiology·Daniele PastoriPasquale Pignatelli
Mar 10, 2015·Lancet·Jeffrey B WashamUNKNOWN ROCKET AF Steering Committee and Investigators
Citations
Oct 28, 2016·Journal of Clinical Pharmacy and Therapeutics·M BitekerC Kırma
Oct 26, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Seema Patel
Aug 22, 2017·International Journal of Clinical Pharmacy·Alaa Abdullah RahhalLylia Mekideche
May 12, 2019·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Ying GaoChangsheng Ma
Jun 27, 2019·Current Cardiology Reviews·Filipe FerrariRicardo Stein
Feb 6, 2021·Pharmacotherapy·William L BakerRobert J DiDomenico
Oct 19, 2021·Frontiers in Cardiovascular Medicine·Xiaoxu WangKun Zhao
Jun 13, 2019·Cardiology·Tobias SchuppIbrahim Akin